The (cost-)effectiveness of mindfulness-based cognitive therapy and cognitive-behavioral treatment in adolescents and young adults with deliberate self-harm

The (cost-)effectiveness of mindfulness-based cognitive therapy and cognitive-behavioral treatment in adolescents and young adults with deliberate self-harm - Short-term psychological treatments of deliberate self-harm

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31032

Enrollment

126

Registered

2007-08-13

Start date

2007-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deliberate self-harm

Interventions

Participants are randomly allocated to CBT, Mindfulness-Based Cognitive Therapy (MBCT) or Treatment-as-Usual (TAU). The CBT treatment consists of up to 12 weekly sessions of individual treatment mai

Eligibility

Age

12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adolescents and young adults aged 15-35 years who recently engaged in self-harming behaviour, regardless of the intent (e.g. trying to hurt or kill oneself), will be included after referral to the Leiden University Medical Center, Rivierduinen or the University Medical Centre St. Radboud following their act of DSH .

Exclusion criteria

Exclusion criteria: Persons (a) reporting severe psychiatric disorders requiring intensive inpatient treatment (such as schizophrenia or problems with alcohol and drugs), (b) unable to converse in Dutch, (c) manifesting serious cognitive impairments, or (d) living outside the region of Leiden or Nijmegen will be excluded.

Design outcomes

Primary

Measure	Time frame
As in the previous study patients are asked for the exact number of episodes of DSH during the past 3 months using a semi-structured interview.	—

Secondary

Measure	Time frame
Also the same secondary outcome measures as in he previous study will be used ( depression (BDI-II), anxiety (SCL-90), self-concept (RSC-Q), and suicide cognitions (SCS)). In addition at all assessments health-related quality of life, use of medical resources and loss of productivity will be assessed (EuroQol, VAS and TTO). Also, problems in emotion regulation will be assessed before and after treatment (AMT and DERS).	—

Measure

Time frame

Also the same secondary outcome measures as in he previous study will be used ( depression (BDI-II), anxiety (SCL-90), self-concept (RSC-Q), and suicide cognitions (SCS)). In addition at all assessments health-related quality of life, use of medical resources and loss of productivity will be assessed (EuroQol, VAS and TTO). Also, problems in emotion regulation will be assessed before and after treatment (AMT and DERS).

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)